Jonathan Wall receives $1.79 million to develop new amyloidosis treatment

(University of Tennessee Health Science Center) The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center's Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled " Developing a Theranostic Immunotherapy for Systemic Amyloidosis. "
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news